{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T17:29:04Z","timestamp":1747330144264},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.cyto.2012.07.022","type":"journal-article","created":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T05:46:08Z","timestamp":1346046368000},"page":"843-848","source":"Crossref","is-referenced-by-count":8,"title":["Differential expression of pro-inflammatory cytokines in intra-epithelial T cells between trachea and bronchi distinguishes severity of COPD"],"prefix":"10.1016","volume":"60","author":[{"given":"Greg","family":"Hodge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul N.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2012.07.022_b0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nri2254","article-title":"Immunology of asthma and chronic obstructive pulmonary disease","volume":"8","author":"Barnes","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2012.07.022_b0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2249.2007.03451.x","article-title":"Increased intracellular Th1 pro-inflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects","volume":"150","author":"Hodge","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cyto.2012.07.022_b0015","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1183\/09031936.03.00040703","article-title":"Chronic obstructive pulmonary disease: molecular and cellular mechanisms","volume":"22","author":"Barnes","year":"2003","journal-title":"Eur Resp J"},{"key":"10.1016\/j.cyto.2012.07.022_b0090","series-title":"Human Cytokines","article-title":"Tumour Necrosis Factor","author":"Aggarwal","year":"1995"},{"key":"10.1016\/j.cyto.2012.07.022_b0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1465-9921-7-70","article-title":"Chronic obstructive pulmonary disease, inflammation and co-morbidity \u2013 a common inflammatory phenotype?","volume":"7","author":"Sevenoaks","year":"2006","journal-title":"Resp Res"},{"key":"10.1016\/j.cyto.2012.07.022_b0030","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1152\/ajplung.00014.2004","article-title":"Fractaline\/CX3CL1 production by human airway smooth muscle cells: induction by IFN-\u03b3 and TNF-\u03b1 and regulation by TGF-\u03b2 and corticosteroids","volume":"287","author":"Sukkar","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"10.1016\/j.cyto.2012.07.022_b0035","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/eji.200425097","article-title":"Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-inflammatory cytokine TNF-\u03b1","volume":"34","author":"Shinbori","year":"2004","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.cyto.2012.07.022_b0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.1440-1711.2003.t01-1-01170.x","article-title":"Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells","volume":"81","author":"Hodge","year":"2003","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"10.1016\/j.cyto.2012.07.022_b0045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1183\/09031936.05.00077604","article-title":"Increased apoptosis in the airways in COPD persists after smoking cessation","volume":"25","author":"Hodge","year":"2005","journal-title":"Eur Resp J"},{"key":"10.1016\/j.cyto.2012.07.022_b0050","unstructured":"Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2011. <http:\/\/www.goldcopd.org\/>. [cited 28 January 2012]."},{"issue":"3","key":"10.1016\/j.cyto.2012.07.022_b0055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2249.2006.03143.x","article-title":"Compartmentalisation of intracellular proinflammatory cytokines in bronchial intraepithelial T cells of stable lung transplant patients","volume":"145","author":"Hodge","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2012.07.022_b0060","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2249.2010.04186.x","article-title":"Time post-lung transplant correlates with increasing peripheral blood T-cell granzyme B and pro-inflammatory cytokines","volume":"161","author":"Hodge","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cyto.2012.07.022_b0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1164\/rccm.200404-511OC","article-title":"Tumour necrosis factor alpha drives 70% of cigarette smoke-induced emphysema in the mouse","volume":"170","author":"Churg","year":"2004","journal-title":"AM J Resp Care Med"},{"key":"10.1016\/j.cyto.2012.07.022_b0070","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1164\/rccm.200607-995OC","article-title":"The safety and efficiency of infliximab in moderate-to-severe chronic obstructive pulmonary disease","volume":"175","author":"Rennard","year":"2007","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.cyto.2012.07.022_b0075","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pupt.2007.03.003","article-title":"TNF-\u03b1 antagonists and the prevention of hospitalization for chronic obstructive pulmonary disease","volume":"21","author":"Suissa","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.cyto.2012.07.022_b0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0167-5699(97)80019-9","article-title":"The Th1\/Th2 paradigm","volume":"18","author":"Romagnani","year":"1997","journal-title":"Immunol Today"},{"key":"10.1016\/j.cyto.2012.07.022_b0085","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1513\/pats.200504-045SR","article-title":"Pathogenesis of chronic obstructive pulmonary disease","volume":"2","author":"MacNee","year":"2005","journal-title":"Proc Am Thorac Soc"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612006047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612006047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T07:27:23Z","timestamp":1542785243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466612006047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1043466612006047"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2012.07.022","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}